USA - NASDAQ:UPB - US91678A1079 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to UPB. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating | 
|---|---|---|---|
| 2025-10-14 | Truist Securities | Initiate | Buy | 
| 2024-11-05 | TD Cowen | Initiate | Buy | 
| 2024-11-05 | William Blair | Initiate | Outperform | 
| 2024-11-05 | JP Morgan | Initiate | Overweight | 
| 2024-11-05 | Piper Sandler | Initiate | Overweight | 
8 analysts have analysed UPB and the average price target is 76.5 USD. This implies a price increase of 196.86% is expected in the next year compared to the current price of 25.77.
The consensus rating for UPSTREAM BIO INC (UPB) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering UPSTREAM BIO INC (UPB) is 8.